Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,216 | 331 | 71.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,520 | 2 | 17.6% |
| Education | $909.00 | 8 | 10.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Surgi-Care, Inc. | $2,260 | 3 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $1,243 | 35 | $0 (2024) |
| PFIZER INC. | $777.06 | 69 | $0 (2024) |
| GlaxoSmithKline, LLC. | $677.06 | 46 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $505.26 | 25 | $0 (2024) |
| Astellas Pharma US Inc | $250.24 | 9 | $0 (2024) |
| Ironshore Pharmaceuticals Inc. | $232.43 | 3 | $0 (2019) |
| Amgen Inc. | $213.67 | 10 | $0 (2022) |
| Merck Sharp & Dohme LLC | $200.03 | 12 | $0 (2024) |
| Novo Nordisk Inc | $179.70 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $449.39 | 16 | Janssen Pharmaceuticals, Inc ($134.56) |
| 2023 | $1,031 | 33 | Janssen Pharmaceuticals, Inc ($319.03) |
| 2022 | $559.59 | 42 | Biohaven Pharmaceutical Holding Company Ltd. ($150.22) |
| 2021 | $361.16 | 19 | Janssen Pharmaceuticals, Inc ($90.51) |
| 2020 | $870.64 | 49 | Janssen Pharmaceuticals, Inc ($205.16) |
| 2019 | $2,223 | 61 | Surgi-Care, Inc. ($780.00) |
| 2018 | $1,690 | 64 | Surgi-Care, Inc. ($740.00) |
| 2017 | $1,461 | 57 | Surgi-Care, Inc. ($740.00) |
All Payment Transactions
341 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.31 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $26.37 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: VACCINE | ||||||
| 10/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Biological | ||||||
| 09/17/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Neuroscience | ||||||
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $29.29 | General |
| 05/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Biological | ||||||
| 04/11/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Endocrinology | ||||||
| 03/28/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $115.46 | General |
| Category: Neuroscience | ||||||
| 03/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: VACCINES | ||||||
| 02/15/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: CNS | ||||||
| 01/18/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.88 | General |
| 01/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.77 | General |
| 01/03/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: CONTRACEPTIVE | ||||||
| 12/14/2023 | SANOFI PASTEUR INC. | BEYFORTUS (Biological), VAXELIS | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Vaccines | ||||||
| 11/30/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $165.59 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2023 | SANOFI PASTEUR INC. | BEYFORTUS (Biological), VAXELIS | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Vaccines | ||||||
| 11/16/2023 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Opioid Use Disorder | ||||||
| 11/02/2023 | Merck Sharp & Dohme LLC | PROQUAD (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: VACCINE | ||||||
| 10/26/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $108.60 | General |
| Category: Neuroscience | ||||||
| 10/18/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: PSYCHIATRY | ||||||
| 08/31/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.08 | General |
| Category: Cardiovascular | ||||||
| 08/28/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.97 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 3,699 | 9,473 | $913,137 | $465,954 |
| 2022 | 44 | 3,190 | 7,789 | $777,647 | $392,979 |
| 2021 | 43 | 3,423 | 8,430 | $951,967 | $490,778 |
| 2020 | 34 | 2,893 | 8,318 | $1.1M | $472,839 |
All Medicare Procedures & Services
166 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 418 | 1,472 | $279,680 | $140,841 | 50.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 313 | 313 | $87,640 | $42,236 | 48.2% |
| 97124 | Therapy procedure using massage, each 15 minutes | Office | 2023 | 80 | 1,948 | $97,400 | $36,774 | 37.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 132 | 256 | $64,000 | $36,508 | 57.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 287 | 529 | $66,125 | $35,662 | 53.9% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 185 | 186 | $28,100 | $23,897 | 85.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 136 | 411 | $61,380 | $21,093 | 34.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 19 | 1,686 | $30,806 | $19,842 | 64.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 202 | 203 | $22,330 | $16,697 | 74.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 195 | 195 | $16,515 | $14,016 | 84.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 185 | 186 | $18,600 | $7,803 | 41.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 219 | 220 | $10,340 | $6,923 | 67.0% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 33 | 61 | $12,200 | $6,643 | 54.5% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 24 | 24 | $6,000 | $5,549 | 92.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 31 | 31 | $8,680 | $5,347 | 61.6% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 127 | 127 | $12,700 | $5,286 | 41.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $5,100 | $4,809 | 94.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 37 | 37 | $4,415 | $4,327 | 98.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 35 | 38 | $5,700 | $4,025 | 70.6% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 63 | $6,930 | $3,684 | 53.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 67 | 82 | $8,200 | $3,285 | 40.1% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 72 | 72 | $6,480 | $3,133 | 48.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 71 | 71 | $3,337 | $2,234 | 67.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,125 | $1,935 | 46.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 50 | 142 | $6,390 | $1,602 | 25.1% |
About Dr. Katherine Atkinson, MD
Dr. Katherine Atkinson, MD is a Family Medicine healthcare provider based in Amherst, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700849643.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katherine Atkinson, MD has received a total of $8,645 in payments from pharmaceutical and medical device companies, with $449.39 received in 2024. These payments were reported across 341 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($6,216).
As a Medicare-enrolled provider, Atkinson has provided services to 13,205 Medicare beneficiaries, totaling 34,010 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 166 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Amherst, MA
- Active Since 04/11/2006
- Last Updated 04/25/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1700849643
Products in Payments
- SPRAVATO (Drug) $667.93
- CHANTIX (Drug) $538.95
- XARELTO (Drug) $469.92
- FARXIGA (Drug) $320.08
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $232.43
- SHINGRIX (Biological) $228.46
- NURTEC ODT (Drug) $186.16
- TRELEGY ELLIPTA (Drug) $173.50
- MYRISK (Device) $165.59
- ELIQUIS (Drug) $150.51
- BREO (Drug) $138.29
- INTRAROSA (Drug) $129.80
- INVOKANA (Drug) $105.05
- Aimovig (Biological) $102.07
- UBRELVY (Drug) $91.65
- JARDIANCE (Drug) $80.55
- VRAYLAR (Drug) $78.60
- MYRBETRIQ (Drug) $76.68
- BEXSERO (Biological) $72.84
- REXULTI (Drug) $65.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Amherst
Michael Slater, Do, DO
Family Medicine — Payments: $16,378
Dr. Timothy Wagner, Do, DO
Family Medicine — Payments: $10,594
Mrs. Janelle Young, Pa-C, PA-C
Family Medicine — Payments: $10,275
Jennifer Calabrese, Md, MD
Family Medicine — Payments: $10,251
Dr. Frances Ilozue, Md, Mph, MD, MPH
Family Medicine — Payments: $4,788
Ronald Carissimi, M.d, M.D
Family Medicine — Payments: $4,661